🇺🇸 FDA
Pipeline program

Cellular Matrix / A-CP-HA Kit

FSD-CEL-2023-11

Approved small_molecule active

Quick answer

Cellular Matrix / A-CP-HA Kit for Genitourinary Syndrome of Menopause is a Approved program (small_molecule) at Regen BioPharma Inc with 1 ClinicalTrials.gov record(s).

Program details

Company
Regen BioPharma Inc
Indication
Genitourinary Syndrome of Menopause
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials